Earnings Feed
Start Free
Home/Filings/3/0000899243-23-020705
3//SEC Filing

BCIP Life Sciences Associates, LP 3

Accession 0000899243-23-020705

CIK 0001936258other
View on SEC.govCompany Profile

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 5:09 PM ET

Size

24.1 KB

Accession

0000899243-23-020705

Insider Transaction Report

Form 3
Period: 2023-12-29
NewAmsterdam Pharma Co N.V.NAMS
Bain Capital Life Sciences Investors, LLC
10% Owner
Holdings

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913
BCLS Fund III Investments, LP
10% Owner
Holdings

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913
BCLS II Investco, LP
10% Owner
Holdings

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)
BCIP Life Sciences Associates, LP
10% Owner
Holdings

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)
Bain Capital Life Sciences Investors II, LLC
10% Owner
Holdings

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)
Bain Capital Life Sciences Fund III, L.P.
10% Owner
Holdings

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)
Bain Capital Life Sciences Fund II, L.P.
10% Owner
Holdings

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)
BCLS Fund III Investments GP, LLC
10% Owner
Holdings

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)
Bain Capital Life Sciences III General Partner, LLC
10% Owner
Holdings

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)
BCLS II Investco (GP), LLC
10% Owner
Holdings

  • Warrant (right to buy)

    (indirect: See footnotes)
    Exercise: $11.50From: 2022-12-22Exp: 2027-11-23→ Ordinary Shares (100,000 underlying)

  • Ordinary Shares

    (indirect: See footnotes)
    10,473,913
Footnotes (7)
  • [F1]Represents 5,376,356 Ordinary Shares held directly by BCLS Fund III Investments, LP ("BCLS Fund III"), 4,797,557 Ordinary Shares held directly by BCLS II Investco, LP ("BCLS II Investco"), 267,429 Ordinary Shares held directly by Bain Capital Life Sciences Fund II, L.P. ("BCLS Fund II") and 32,571 Ordinary Shares held directly by BCIP Life Sciences Associates, LP ("BCIPLS" and, together with BCLS Fund III, BCLS II Investco and BCLS Fund II, the "Bain Capital Life Sciences Entities").
  • [F2]Represents a warrant to purchase 89,143 Ordinary Shares held directly by BCLS Fund II and a warrant to purchase 10,857 Ordinary Shares held directly by BCIPLS.
  • [F3]Bain Capital Life Sciences III General Partner LLC ("BCLS III GP") is the general partner of Bain Capital Life Sciences Fund III, L.P. ("BCLS III"), which is the managing member of BCLS Fund III Investments GP, LLC ("BCLS Fund III GP"), which is the general partner of BCLS Fund III. As a result, each of BCLS III GP, BCLS III and BCLS Fund III GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund III. Each of BCLS III GP, BCLS III and BCLS Fund III GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • [F4]Bain Capital Life Sciences Investors II, LLC ("BCLSI II") is the general partner of BCLS Fund II. As a result, BCLSI II may be deemed to share voting and dispositive power with respect to the securities held by BCLS Fund II. BCLSI II disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • [F5]BCLS II Investco (GP), LLC ("BCLS II Investco GP"), whose managing member is BCLS Fund II, is the general partner of BCLS II Investco. As a result, each of BCLSI II, BCLS Fund II and BCLS II Investco GP may be deemed to share voting and dispositive power with respect to the securities held by BCLS II Investco. Each of BCLSI II, BCLS Fund II and BCLS II Investco GP disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
  • [F6]Boylston Coinvestors, LLC is the general partner of BCIPLS.
  • [F7]Bain Capital Life Sciences Investors, LLC ("BCLSI") is the manager of each of BCLS III GP and BCLSI II and governs the investment strategy and decision making process with respect to investments held by BCIPLS. As a result, BCLSI may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. BCLSI disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.

Documents

2 files

Issuer

NewAmsterdam Pharma Co N.V.

CIK 0001936258

→
Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001702921

Filing Metadata

Form type
3
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:09 PM ET
Size
24.1 KB
View on SEC.gov